Baird Downgrades Inhibitex (INHX) to Neutral; Sold to Bristol-Myers (NYSE: BMY) as Run on Hep C Continues
Go back to Baird Downgrades Inhibitex (INHX) to Neutral; Sold to Bristol-Myers (NYSE: BMY) as Run on Hep C Continues| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 63.98 +0.15 (0.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.83 | 52 Week High | $77.12 | |||
| Open | $63.60 | 52 Week Low | $49.03 | |||
| Day High | $64.15 | P/E | 41.55 | |||
| Day Low | $63.36 | EPS | $1.54 | |||
| Volume | 381,873 | |||||
| Inhibitex, Inc. (NASDAQ: INHX) | Delayed: 26.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.00 | 52 Week High | $26.01 | |||
| Open | $1.33 | 52 Week Low | $2.15 | |||
| Day High | $26.00 | P/E | N/A | |||
| Day Low | $26.00 | EPS | $-0.38 | |||
| Volume | 470,537 | |||||
